DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jan 3, 2017
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Other
Common Stock
2016-12-31$3.20/sh+176$563→ 34,969 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.